Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Beta Finch - Income & Dividends - EN cover art

Beta Finch - Income & Dividends - EN

Beta Finch - Income & Dividends - EN

Written by: Beta Finch
Listen for free

About this listen
Reliable dividend payers popular with income-focused investors. AI-powered earnings call analysis for Income & Dividends (INCOME). Two AI hosts break down quarterly results, key metrics, and market implications in digestible podcast episodes.2026 Beta Finch Economics Personal Finance
Episodes
  • McDonald's Q3 2026 Earnings Analysis
    Nov 4 2026
    More earnings analysis: https://betafinch.com
    Groups: RETAIL (https://betafinch.com/groups/RETAIL), INCOME (https://betafinch.com/groups/INCOME)
    ──────────
    **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, joined as always by Jordan, and today we're diving into the Golden Arches — McDonald's Q3 2026 earnings call. This one's got a little bit of everything: a U.S. turnaround story in progress, international strength, and some genuinely interesting strategic moves.

    **JORDAN:** Lots to unpack. There's value menu drama, beverage platform wins, hand-breaded chicken tests — even bone-in wings making a cautious comeback.

    **ALEX:** Before we get into it, quick disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

    **JORDAN:** Okay, with that out of the way — let's talk numbers.

    **ALEX:** So McDonald's posted global comparable sales growth of 1.5% for Q3, with system sales up 4% in constant currency. Adjusted EPS came in at $3.57, which included a one-cent currency headwind — on a constant currency basis, that's EPS growth of 11% year-over-year. Stock actually popped over 6.6% on this report.

    **JORDAN:** Which tells you the market was bracing for worse, especially on the U.S. side. Let's break that down by segment, because the story really differs depending on where you look. U.S. comps were actually down 0.2% for the quarter — but here's the key detail: that masked a real improvement as the quarter progressed. July and August were negative, but September turned positive.

    **ALEX:** And that's not just noise — management specifically tied it to interventions they made mid-quarter. They restored digital offers like a $2 breakfast sandwich and free fries with a $1 purchase, shifted marketing dollars toward value platforms, and leaned harder into operational execution.

    **JORDAN:** The loyalty angle here is huge, by the way. CEO Chris Kempczinski made the point that McDonald's most frequent customers — who make up the majority of sales — are extremely sensitive to digital offers. When they pulled back some of those offers earlier in the year, it apparently hit baseline traffic hard. Putting them back worked almost immediately.

    **ALEX:** Meanwhile, international was the steadier story. International Operated Markets, think Australia, Germany, the U.K., grew comps 1.4%, even with real softness in France and disruption in Ukraine from the war escalation. Strip those two out and IOM actually beats expectations.

    **JORDAN:** And then the International Developmental Licensed Markets — that's the franchise-heavy, licensed structure — grew 4.2%, with Japan leading the way. Forty-four consecutive quarters of comp growth in Japan. That's wild consistency.

    **ALEX:** China was the drag there, given the tough macro environment, though management noted operational efficiency improved profitability even with soft sales.

    **JORDAN:** Let's talk strategy, because this is where it gets interesting for the long-term thesis. McDonald's is leaning hard into what they're calling "McDonald's > NEXT" — basically a multiyear overhaul touching menu, restaurant design, and technology.

    **ALEX:** The headline piece for U.S. investors right now is the value test. McDonald's just launched an eight-week test of two new entry-level value constructs — mix-and-match bundles and fixed bundles — across about 1,900 restaurants. And get this: separately, franchisees covering roughly 4,000 more restaurants didn't even wait for test results — they just started rolling out similar offers on their own.

    **JORDAN:** That's over 40% of the entire U.S. system already moving on this. That's a pretty strong signal of franchisee alignment, which matters a lot given McDonald's heavily-franchised model. They're targeting a national rollout in e

    This episode includes AI-generated content.
    Show More Show Less
    6 mins
  • Colgate-Palmolive Q3 2026 Earnings Analysis
    Oct 30 2026
    More earnings analysis: https://betafinch.com
    Groups: RETAIL (https://betafinch.com/groups/RETAIL), INCOME (https://betafinch.com/groups/INCOME)
    ──────────
    **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

    **JORDAN:** And I'm Jordan. Today we're digging into Colgate-Palmolive's third quarter 2026 results, reported on October 30th.

    **ALEX:** Before we get into it, quick disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

    **JORDAN:** Alright, with that out of the way—Alex, this was actually a pretty strong quarter for a company that's been dealing with a lot of noise.

    **ALEX:** Yeah, let's start with the big picture. Colgate posted organic sales growth across four of its five divisions and all four product categories—oral care, personal care, home care, and pet nutrition. That's broad-based, which matters because it means they're not leaning on just one hot business line.

    **JORDAN:** And the margin story is honestly the headline here. They faced a 300 basis point headwind from material inflation—that's resins, petrochemicals, pulp and paper, all elevated—but their productivity programs, "funding-the-growth" and this newer "Strategic Growth and Productivity Program," offset nearly all of it. CFO Stan Sutula said funding-the-growth alone delivered over 290 basis points of offset.

    **ALEX:** So basically a near-perfect hedge against inflation through internal efficiency rather than just jacking up prices.

    **JORDAN:** Right, and pricing still played a role too—80 basis points of favorable pricing, plus 20 basis points from mix. They've taken pricing every quarter this year: 220 basis points in Q1, 160 in Q2, 200 in Q3. They're clearly trying to stay ahead of the cost curve rather than react to it.

    **ALEX:** Free cash flow was up 7% year-to-date, and they've returned $2.2 billion to shareholders so far this year. That's a healthy capital return story even with all this cost volatility swirling around.

    **JORDAN:** Let's talk geography, because that's really where the story gets interesting. Emerging markets grew mid-single digits, led by India, Brazil, and China.

    **ALEX:** India was a standout—double-digit growth again, driven by premium innovation. China's trickier—the category itself is soft, lots of brick-and-mortar weakness, but Colgate's own China business grew high single digits by leaning hard into e-commerce and social platforms like Douyin.

    **JORDAN:** And Hill's Pet Nutrition—wow. Organic sales up 6.5% ex-private label. Prescription Diet cat was up double digits, dog up mid-single digits. The therapeutic side is really firing, and it's creating a halo effect on the wellness side of that business.

    **ALEX:** They also teased their "Fresh" line—the fresh pet food push with chicken and brown rice, beef and carrot, lamb and pumpkin diets. CEO Noel Wallace was clear they're rolling that out slowly and deliberately, protecting the Hill's brand reputation with vets rather than rushing for a quick win.

    **JORDAN:** Now, let's get to the part analysts clearly wanted more color on: the U.S. turnaround. This was a recurring theme in the Q&A.

    **ALEX:** Right, multiple analysts—Filippo Falorni, Andrea Teixeira—pushed on North America. Wallace acknowledged some green shoots in toothpaste market share, but was candid that this is a multi-quarter rebuild, not a quick fix.

    **JORDAN:** The structural piece was fascinating to me. Colgate is literally restructuring their North American go-to-market model—moving away from a traditional channel-based structure toward one built around digital, social, and what Wallace called "agentic commerce" connections. His quote was something like: the business was built for "a world of channels," but we're now in "a world that runs on connections."

    **ALEX:*

    This episode includes AI-generated content.
    Show More Show Less
    6 mins
  • Altria Q3 2026 Earnings Analysis
    Oct 29 2026
    More earnings analysis: https://betafinch.com
    Groups: INCOME (https://betafinch.com/groups/INCOME)
    ──────────
    **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're digging into Altria's third quarter 2026 results, and there's a lot on the table — from a lawsuit against the FDA to a brand-new flavor lineup for nicotine pouches. I'm Alex, here with Jordan, and we're going to break it all down for you.

    **JORDAN:** Before we get into it — quick reminder, Alex, you know the drill.

    **ALEX:** Right, right. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

    **JORDAN:** Perfect. Okay, let's get into Altria's numbers.

    **ALEX:** So headline first: adjusted diluted EPS grew 4.8% in Q3, and 5.1% through the first nine months of the year. That's solid growth for a company that's often thought of as slow and steady.

    **JORDAN:** And here's the thing that jumped out at me — they actually raised guidance. Full-year adjusted EPS is now expected between $5.66 and $5.74, which works out to 4.5% to 6% growth off last year's $5.42. That's up from their original range of 2.5% to 5%. So management is feeling pretty confident here.

    **ALEX:** Yeah, and that confidence is coming largely from the smokeable products segment, which is still the earnings engine for Altria. Adjusted operating company income there grew 3.9% to $3.1 billion in the quarter. Margins expanded too, up to 64.5%.

    **JORDAN:** What's interesting is how they're doing it. This isn't just pure pricing power — it's a "total portfolio" strategy. Marlboro's holding the premium end, but they've also got Basic gaining share in the discount segment. Basic's retail share jumped 1.8 points year-over-year as more price-pressured smokers trade down.

    **ALEX:** And then there's the new kid — Marlboro Cowboy Cut. It's basically a lower-priced premium option designed to keep value-conscious Marlboro smokers in the franchise instead of losing them to discount brands entirely. It's already in about 100,000 stores, roughly 75% of cigarette volume nationally.

    **JORDAN:** Smart playbook, honestly. They've done this before with Marlboro Special Select and Marlboro Black — launch at an introductory price, then gradually take pricing up over time once it's established. And it seems to be working — Marlboro's share of the premium segment hit 60%, up slightly both year-over-year and sequentially.

    **ALEX:** Now let's talk about the smoke-free side of the business, because this is where things get really interesting strategically. On! nicotine pouches — shipment volume was up 13.3% in the quarter to 47.8 million cans.

    **JORDAN:** But retail share only ticked up 0.1 point year-over-year, and was actually down 0.3 sequentially. That tells you this category is getting fiercely competitive. Everybody's throwing flavors and higher nicotine strengths at the wall right now.

    **ALEX:** Which is exactly what Altria's subsidiary Helix is doing in response — they just rolled out on! PLUS 12-milligram nationally, and they're adding new flavors: Blueberry Mint and Mango Pineapple hit shelves this month, with Watermelon Mint coming in November.

    **JORDAN:** And don't sleep on the marketing push either — they hosted something called the "on!vitational," an invite-only golf tournament in Palm Beach. It's meant to be a recurring, multiyear brand platform. Altria's clearly trying to build lifestyle equity around on!, not just compete on nicotine strength and flavor.

    **ALEX:** Now, here's the part of this call I found most newsworthy — the regulatory fight. Altria's Helix and NJOY subsidiaries actually sued the FDA this quarter.

    **JORDAN:** Yeah, this is a big deal. The lawsuit is asking a court to force the FDA to stick to the 180-day review timeline that Congress set for product authorizatio

    This episode includes AI-generated content.
    Show More Show Less
    8 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet